JP5025254B2 - Cosmetic preparations and cosmetics for improving the skin groove density - Google Patents

Cosmetic preparations and cosmetics for improving the skin groove density Download PDF

Info

Publication number
JP5025254B2
JP5025254B2 JP2006344971A JP2006344971A JP5025254B2 JP 5025254 B2 JP5025254 B2 JP 5025254B2 JP 2006344971 A JP2006344971 A JP 2006344971A JP 2006344971 A JP2006344971 A JP 2006344971A JP 5025254 B2 JP5025254 B2 JP 5025254B2
Authority
JP
Japan
Prior art keywords
skin
prototype
dna
cosmetic
cosmetics
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2006344971A
Other languages
Japanese (ja)
Other versions
JP2008063315A (en
Inventor
政司 松永
文人 吉田
孝男 盛
正人 杉
英司 長谷川
Original Assignee
日生バイオ株式会社
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 日生バイオ株式会社 filed Critical 日生バイオ株式会社
Priority to JP2006344971A priority Critical patent/JP5025254B2/en
Priority to KR1020070052609A priority patent/KR20080013702A/en
Priority to US11/902,764 priority patent/US20080153741A1/en
Priority to EP07019175A priority patent/EP1938794A2/en
Priority to CNA2007101691948A priority patent/CN101259084A/en
Publication of JP2008063315A publication Critical patent/JP2008063315A/en
Application granted granted Critical
Publication of JP5025254B2 publication Critical patent/JP5025254B2/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/64Proteins; Peptides; Derivatives or degradation products thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/02Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0212Face masks
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/60Sugars; Derivatives thereof
    • A61K8/606Nucleosides; Nucleotides; Nucleic acids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/98Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin
    • A61K8/987Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution of animal origin of species other than mammals or birds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00Cosmetics or similar toiletry preparations
    • A61K8/18Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/99Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from microorganisms other than algae or fungi, e.g. protozoa or bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/02Preparations containing skin colorants, e.g. pigments
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61QSPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00Preparations for care of the skin
    • A61Q19/08Anti-ageing preparations

Description

本発明はヒトの皮膚(肌)細胞の再生又は活性化を促し皮溝密度(きめ)を改良する、化粧品用配合剤、並びに該化粧品用配合剤を含有する化粧品に関するものである。   The present invention relates to a cosmetic formulation that promotes the regeneration or activation of human skin (skin) cells and improves the crevice density (texture), and a cosmetic containing the cosmetic formulation.

肌荒れ及びしみ等は、加齢によるホルモンのバランスの影響、日光からの紫外線の刺激、体内の過酸化物濃度の高まりによる表皮への悪影響、皮脂の過剰分泌、表皮への血流量の低下、栄養不良、精神的なストレスなど種々の事柄が原因で起こると考えられている。
顔の肌荒れ及びしわ等が人々の美容上の重大な関心事であることは、近年、女性向けに限らず、男性向け化粧品の製品数の増加にも現れている。顔が他人への第一印象を与える大きな要素となることから、老若男女を問わず艶やかで張りのある肌(美肌)でありたいと切に願う人は多く、それ故、肌荒れ及びしわ等を改善する化粧品に関する世間一般の関心がさらに高まっている。
Rough skin and stains include effects of hormonal balance due to aging, stimulation of ultraviolet rays from sunlight, adverse effects on the epidermis due to increased peroxide concentration in the body, excessive secretion of sebum, decreased blood flow to the epidermis, nutrition It is thought to be caused by various things such as badness and mental stress.
The fact that rough skin and wrinkles are a serious concern for people's beauty has recently appeared in an increase in the number of cosmetic products for men as well as for women. Because the face is a big factor that gives a first impression to others, many people want to have glossy and firm skin (beautiful skin) regardless of age or gender, therefore rough skin and wrinkles The general public's interest in cosmetics that improve the quality of the cosmetics is increasing.

従来の化粧品において、グリセリン等の保湿剤や油成分を入れることにより、肌の保湿効果を高め、艶やかな肌とすることが多く試みられていた。最近では肌への美肌効果を意図して、メラニン生成を抑制しコラーゲン生産を促進する働きを有するL−アスコルビン酸及びその誘導体などを含有する化粧品が登場している。   In conventional cosmetics, many attempts have been made to enhance the moisturizing effect of the skin by adding a moisturizing agent such as glycerin or an oil component to make the skin glossy. Recently, cosmetics containing L-ascorbic acid and its derivatives, which have the function of suppressing melanin production and promoting collagen production, have been introduced with the intention of having a beautiful skin effect.

ところで、近年、健康に対する世間一般の関心の高まりを反映して、デオキシリボ核酸(DNA)、リボ核酸(RNA)又は核タンパク質を原料又は有効成分として用いた健康食品が提供されている。高分子量の核タンパク質を水可溶性及び易消化性とするために、低分子化することも提案されている(特許文献1)。
デオキシリボ核酸(DNA)、リボ核酸(RNA)又は核タンパク質は老化防止効果を有することは知られているが、化粧品に適用する試みは充分に成されていない。
特開2004−16143号公報
Meanwhile, in recent years, health foods using deoxyribonucleic acid (DNA), ribonucleic acid (RNA) or nucleoprotein as raw materials or active ingredients have been provided, reflecting the increasing public interest in health. In order to make high molecular weight nucleoprotein water-soluble and easily digestible, it has also been proposed to reduce the molecular weight (Patent Document 1).
Although deoxyribonucleic acid (DNA), ribonucleic acid (RNA) or nucleoprotein is known to have an anti-aging effect, attempts to apply it to cosmetics have not been made sufficiently.
JP 2004-16143 A

肌荒れ及びしわ等の肌トラブルの原因は、顔面の皮膚の老化、血行不良、紫外線の影響、ストレスなど種々であるが、皮膚の細胞の新陳代謝が低下し、新しい細胞の再生機能が落ちることが直接的な原因である。
従来の化粧品は、皮膚細胞の新陳代謝のメカニズムに働きかけて機能を発揮するものではなく、単に肌の表面上の効果を追求しているに過ぎなかった。このため、肌荒れ及びしわ等に対して充分といえるまでの効果は得られていない。
また、前述のL−アスコルビン酸及びその誘導体を適用する方法においては、安定的でなく且つ紫外線炎症防止効果が不十分であることから、前記化合物の含有成分を化粧品の有効成分として直接的に求めることは困難である。
すなわち、ヒトの皮膚細胞の再生能や活性化能を高めて新しい肌細胞の再生を促し、肌荒れやしわ等を防止する、皮膚美肌効果の高い製品が望まれているが、従来の化粧品におけるその効果はまだ充分でない。
それ故、細胞自体を賦活し、生き生きとした肌にする新たな化粧品の開発が望まれていた。
Causes of skin troubles such as rough skin and wrinkles are various, such as facial skin aging, poor blood circulation, the influence of ultraviolet rays, stress, etc., but the decrease in skin cell metabolism and the renewal function of new cells directly Cause.
Conventional cosmetics do not work by acting on the metabolism mechanism of skin cells, but merely pursue effects on the surface of the skin. For this reason, the effect until it can be said sufficient with respect to rough skin, wrinkles, etc. is not acquired.
Moreover, in the method of applying the above-mentioned L-ascorbic acid and its derivative, since it is not stable and the ultraviolet-ray inflammation prevention effect is inadequate, the content component of the said compound is calculated | required directly as an active ingredient of cosmetics. It is difficult.
In other words, there is a demand for a product with a high skin beautifying effect that enhances the regenerative and activating ability of human skin cells to promote the regeneration of new skin cells and prevents rough skin and wrinkles. The effect is still not enough.
Therefore, it has been desired to develop a new cosmetic product that activates the cells themselves to make the skin alive.

本発明者らは、ヒトの肌のきめを改良する新たな化粧品を得るべく鋭意研究した結果、ヌクレオプロテイン及び/又はDNAを酵素分解処理又は加水分解処理して得られた、デオキシオリゴヌクレオチド、デオキシモノヌクレオチド又はオリゴペプチドを含有する分
解物、或いは、RNAを酵素分解処理又は加水分解処理して得られた、オリゴヌクレオチド又はモノヌクレオチドを含有する分解物、或いは、それらの混合物に、優れた細胞再生、細胞活性化効果があることを見出し、これにより皮溝密度の改良効果、皮膚の水分保持能や皮脂量のバランスの改善効果、さらにはしわ等の防止効果につながることを発見し、本発明を完成させた。
As a result of earnest research to obtain a new cosmetic product that improves the texture of human skin, the present inventors have obtained a deoxyoligonucleotide, deoxynucleotide obtained by enzymatic or hydrolytic treatment of nucleoprotein and / or DNA. Excellent cell regeneration for degradation products containing mononucleotides or oligopeptides, or degradation products containing oligonucleotides or mononucleotides obtained by enzymatic degradation or hydrolysis of RNA, or mixtures thereof And found that it has a cell activation effect, which leads to an improvement effect of the skin groove density, an improvement effect of the moisture retention ability of the skin and a balance of sebum amount, and an effect of preventing wrinkles, etc. Was completed.

即ち、本発明による化粧品用配合剤は、RNAを酵素分解処理又は加水分解処理により低分子化して得られた分子量1000乃至3000の画分であって、鎖長が2乃至12のオリゴヌクレオチドを20乃至50%含有するRNA分解生成物を含有する皮溝密度を改良する化粧品用配合剤である(但しβ−アラニンを含有する配合剤を除く)。
前記RNA分解生成物は、鎖長が2乃至12のオリゴヌクレオチドを41.1%含有するものであることが好ましい。
或いは、本発明による皮溝密度を改良する化粧用配合剤は、前記RNA分解生成物に加えて、さらにヌクレオプロテイン及びDNAを酵素分解処理又は加水分解処理により低分子化して得られた分子量1000乃至3000の画分であって、鎖長が2乃至12のデオキシオリゴヌクレオチドを20乃至50%含有するヌクレオプロテイン分解生成物及びDNA分解生成物を含有し得る。
That is, the cosmetic compounding agent according to the present invention is a fraction having a molecular weight of 1000 to 3000 obtained by reducing the molecular weight of RNA by enzymatic degradation or hydrolysis, and 20 to 20 oligonucleotides having a chain length of 2 to 12. It is a cosmetic preparation for improving the crevice density containing RNA degradation products containing up to 50% (except for a preparation containing β-alanine).
The RNA degradation product preferably contains 41.1% of an oligonucleotide having a chain length of 2 to 12.
Alternatively, the cosmetic compounding agent for improving the crevice density according to the present invention has a molecular weight of 1,000 to 1,000 obtained by further reducing the molecular weight of nucleoprotein and DNA by enzymatic degradation or hydrolysis in addition to the RNA degradation product. The fraction of 3000 may contain nucleoprotein degradation products and DNA degradation products containing 20-50% deoxyoligonucleotides with chain lengths of 2-12.

本発明の化粧品用配合剤の好ましい態様において、前記ヌクレオプロテイン及びDNAは鮭、鱒、鰊及び鱈などの魚類の白子から得ることが好ましい。
また、前記RNAは、酵母から得られ、好ましくはビール酵母、トルラ酵母、乳酵母及びパン酵母からなる群より選択される酵母から得られる。
In a preferred embodiment of the cosmetic compounding agent of the present invention, the nucleoprotein and DNA are preferably obtained from fish larvae such as salmon, salmon, salmon and salmon.
The RNA is obtained from yeast, preferably from yeast selected from the group consisting of beer yeast, torula yeast, milk yeast and baker's yeast.

さらに本発明による化粧品は、前記皮溝密度を改良する化粧品用配合剤を含有することを特徴とする。   Furthermore, the cosmetic product according to the present invention is characterized by containing a cosmetic compounding agent for improving the skin groove density.

本発明の化粧品用配合剤は、ヌクレオプロテイン及び/又はDNA又はRNAを酵素分解処理又は加水分解処理により低分子化して得られた分子量1000乃至3000の画分を20乃至50%含有する分解生成物、該分解生成物から分離したデオキシオリゴヌクレオチド、デオキシモノヌクレオチド、オリゴペプチド、オリゴヌクレオチド、モノヌクレオチド、或いは前記分解生成物又は前記化合物から選択された少なくとも2種の混合物を有効成分として含有するものである。
該デオキシオリゴヌクレオチド等は分子量が比較的小さいので経皮的に吸収され易く、またそれらは経皮的に吸収されたとき、皮膚の細胞再生能又は細胞活性化能を高める働きを有する。したがって、顔面の表皮に適用した場合、皮溝密度(きめ)の改良、水分量・皮脂量の改善、さらにはしわの改善にも効果を発揮し、皮膚美肌効果を奏する。
The cosmetic compounding agent of the present invention is a degradation product containing 20 to 50% of a fraction having a molecular weight of 1000 to 3000 obtained by reducing the molecular weight of nucleoprotein and / or DNA or RNA by enzymatic degradation or hydrolysis. A deoxyoligonucleotide, deoxymononucleotide, oligopeptide, oligonucleotide, mononucleotide separated from the degradation product, or a mixture of at least two selected from the degradation product or the compound as an active ingredient is there.
Since the deoxyoligonucleotides and the like have a relatively small molecular weight, they are easily absorbed percutaneously, and when absorbed percutaneously, they have a function of enhancing the cell regenerative ability or cell activation ability of the skin. Therefore, when applied to the epidermis of the face, it is effective in improving the skin groove density (texture), moisture and sebum, and further improving wrinkles.

また本発明の化粧品は、上記化粧品用配合剤を含んでなるので、顔面の表皮に適用した場合に該化粧品配合剤が有する優れた肌荒れ、しわ等を防止し、皮膚美肌効果を奏する。   In addition, since the cosmetic of the present invention comprises the above-mentioned cosmetic compounding agent, when applied to the epidermis of the face, the cosmetic compounding agent has excellent skin roughness, wrinkles and the like, and has a skin beautifying effect.

本発明の化粧品用配合剤の有効成分として、精製品としても使用されるデオキシオリゴヌクレオチド又はデオキシモノヌクレオチドは、DNAを酵素分解処理又は加水分解処理して、オリゴヌクレオチド又はモノヌクレオチドは、RNAを酵素分解処理又は加水分解処理して、またオリゴペプチドは、ヌクレオプロテインを酵素分解処理又は加水分解処理して、それぞれ得ることができる。   The deoxyoligonucleotide or deoxymononucleotide used as a refined product as an active ingredient of the cosmetic compounding agent of the present invention is obtained by subjecting DNA to an enzymatic degradation treatment or hydrolysis treatment, and the oligonucleotide or mononucleotide is an enzyme that transforms RNA into an enzyme The oligopeptide can be obtained by subjecting a nucleoprotein to an enzymatic degradation treatment or a hydrolysis treatment, respectively.

DNA及びヌクレオプロテインは、例えば、魚類の白子から抽出し、精製することにより得ることができる。前記魚類は、例えば、鮭、鱒、鰊及び鱈であり、とりわけ、鮭が好ましい。   DNA and nucleoprotein can be obtained, for example, by extracting and purifying from fish larvae. Examples of the fish include salmon, salmon, salmon and salmon, and salmon is particularly preferable.

以下、DNAについて更に詳しく説明する。
本発明の化粧品用配合剤の製造原料であるDNAは種々の態様のものでよく、例えば、二本鎖、一本鎖又は環状のDNAであってよい。DNAの供給源は、動物、植物、微生物等の様々な生物である。水産加工上の廃棄物である、魚類特に鮭、鱒、鰊及び鱈の精巣(白子)は、とりわけDNAを多く含むが、従来、資源として有効に利用されず、多くが廃棄されていた。それ故、廃棄物の資源化という観点からも、これらの精巣由来のDNAを利用することは望ましい。また、哺乳動物や鳥類、例えばウシ、ブタ、ニワトリ等の胸腺から得られるDNAを使用することができる。更に、合成DNAもまた使用することができる。
Hereinafter, DNA will be described in more detail.
The DNA that is the raw material for producing the cosmetic compounding agent of the present invention may have various forms, for example, double-stranded, single-stranded or circular DNA. The source of DNA is various organisms such as animals, plants, and microorganisms. Fish, particularly sharks, sharks, sharks, and shark testes (shirako), which are wastes from marine processing, contain a lot of DNA, but they have not been effectively used as resources, and many of them have been discarded. Therefore, it is desirable to use these testis-derived DNA also from the viewpoint of waste recycling. In addition, DNA obtained from thymus of mammals and birds, for example, cows, pigs, chickens and the like can be used. In addition, synthetic DNA can also be used.

なお、魚類白子からDNAを得るには、特開2005−245394号公報に記載の抽出・精製方法を用いることができる。
具体的には、まず魚類白子を粗砕し、粗砕した魚類白子にDNAが分解しない条件下でタンパク質分解酵素(プロテアーゼ)処理を行い、酵素処理した溶液を濾過する。そして分画分子量が2,000〜1,000,000である中空糸膜を用いて濾液に透析処理を行い、分解したタンパク質およびイオン類を除去すると共に二本鎖DNAを濃縮する。さらに、透析処理を行った溶液から二本鎖DNA塩として沈殿させるかあるいは溶液を濃縮し、これら沈殿物あるいは濃縮物を回収する。
上記方法により得られたDNA塩を乾燥させた粉末状DNA塩を、本発明の化粧品用配合剤の製造原料として用いることができる。
In addition, in order to obtain DNA from a fish white child, the extraction / purification method described in JP-A-2005-245394 can be used.
Specifically, firstly, the larvae of the fish are crushed, the crushed fish larvae are subjected to a proteolytic enzyme (protease) treatment under conditions where DNA is not degraded, and the enzyme-treated solution is filtered. The filtrate is dialyzed using a hollow fiber membrane having a molecular weight cut off of 2,000 to 1,000,000 to remove decomposed proteins and ions and concentrate double-stranded DNA. Further, the dialysis solution is precipitated as a double-stranded DNA salt, or the solution is concentrated, and the precipitate or concentrate is recovered.
A powdered DNA salt obtained by drying the DNA salt obtained by the above method can be used as a raw material for producing the cosmetic compounding agent of the present invention.

RNAは、ビール酵母、トルラ酵母、乳酵母及びパン酵母からなる群より選択される酵母から抽出し、精製することにより得ることができる。   RNA can be obtained by extracting and purifying from a yeast selected from the group consisting of beer yeast, torula yeast, milk yeast and baker's yeast.

DNA及びRNAを処理する酵素は、例えば、ヌクレアーゼであり、とりわけ、アオカビ由来のヌクレアーゼが好ましい。   The enzyme that processes DNA and RNA is, for example, a nuclease, and particularly, a nuclease derived from blue mold.

オリゴペプチドは、魚類の白子などに含まれるヌクレオプロテイン(核タンパク質)をプロテアーゼ及びヌクレアーゼで加水分解して得られる。   Oligopeptides can be obtained by hydrolyzing nucleoprotein (nuclear protein) contained in fish larvae with protease and nuclease.

前記プロテアーゼはトリプシンを主体とするものである。トリプシンは高い特異性を有するセリンプロテアーゼであり、アルギニン及びリジンのカルボキシル側でペプチド結合を選択的に加水分解するので、アルギニンを多く含むプロタミンの加水分解に適している。また前記プロテアーゼは、トリプシンに加えて、他のプロテアーゼ、例えばキモトリプシン等を含むこともできる。良好なプロテアーゼとしては、ノボザイムズジャパン株式会社製のプロテアーゼを挙げることができる。   The protease is mainly composed of trypsin. Trypsin is a serine protease having high specificity and selectively hydrolyzes peptide bonds on the carboxyl side of arginine and lysine, and is therefore suitable for hydrolysis of protamine containing a large amount of arginine. The protease can also contain other proteases such as chymotrypsin in addition to trypsin. An example of a good protease is a protease manufactured by Novozymes Japan.

前記ヌクレアーゼは、デオキシリボ核酸(DNA)及びリボ核酸(RNA)の3',5'−ホスホジエステル結合を加水分解し、オリゴ体重合の5'−(デオキシ)ヌクレオチド
を生成する。該ヌクレアーゼの性質について特に制限はないが、ある程度の熱安定性を備えることが好ましい。このようなヌクレアーゼは、例えば天野エンザイム株式会社、シグマ社等から市販品として入手可能である。
The nuclease hydrolyzes the 3 ′, 5′-phosphodiester bonds of deoxyribonucleic acid (DNA) and ribonucleic acid (RNA) to produce 5 ′-(deoxy) nucleotides for oligobody polymerization. Although there is no restriction | limiting in particular about the property of this nuclease, It is preferable to provide a certain amount of thermal stability. Such a nuclease is commercially available from, for example, Amano Enzyme Co., Ltd., Sigma Co., etc.

前記ヌクレアーゼを用いたDNA、RNA及びヌクレオプロテインの加水分解処理において重要なのは、反応を行う温度である。反応温度は60〜75℃の範囲内でなければならず、70℃が最も好ましい。該温度範囲より低い温度で反応を行うと、DNA、RNA
及びヌクレオプロテインの低分子化が十分に進行せず、分解物が水溶性とならない。一方、該温度範囲より高い温度で行うと、低分子化が過度に進行し、核タンパク質(ヌクレオプロテイン)の優れた効果を失う惧れがある。
What is important in the hydrolysis treatment of DNA, RNA and nucleoprotein using the nuclease is the temperature at which the reaction is carried out. The reaction temperature must be in the range of 60-75 ° C, most preferably 70 ° C. When the reaction is carried out at a temperature lower than the temperature range, DNA, RNA
In addition, the molecular weight of the nucleoprotein does not sufficiently progress, and the degradation product does not become water-soluble. On the other hand, when the reaction is performed at a temperature higher than the above temperature range, the reduction of the molecular weight proceeds excessively and the excellent effect of the nucleoprotein (nucleoprotein) may be lost.

以上のようにDNA、RNA及びヌクレオプロテインをヌクレアーゼを用い60〜75℃で行う加水分解によって処理することにより、分子量が1000乃至3000である画分を20乃至50%含有し、そして分子量が1000以下である画分を、通常、分子量1000乃至3000の画分の量よりも多い量、例えば30乃至50%含有する程度まで低分子化することができ、これにより、水可溶性及び経皮吸収性を兼ね備えたDNA、RNA及びヌクレオプロテイン分解生成物を製造できる。
以上の処理により得られたヌクレオプロテイン分解生成物及びDNA分解生成物には、低分子化されたデオキシオリゴヌクレオチド、デオキシモノヌクレオチド及びオリゴペプチドが主要な部分もしくは大部分として含まれ、そして低分子化が不十分なデオキシヌクレオチド等がごく少量の部分として含有されている。
また同様の処理により得られたRNA分解生成物にはオリゴヌクレオチド及びモノヌクレオチドが主要な部分もしくは大部分として含まれ、そして低分子化が不十分なヌクレオチド等がごく少量の部分として含有されている。
従って、これら分解生成物に含まれるヌクレオチド類(デオキシオリゴヌクレオチド、デオキシモノヌクレオチド、オリゴヌクレオチド、モノヌクレオチド)は、そのほぼ全て乃至その大部分が、本来らせん鎖を取らないモノ体、完全な一本鎖のオリゴ体、並びに、二重らせん構造を一部にしか有しないオリゴ体で構成される。言い換えると、上述の低分子化が十分に進行しなかったような場合を想定したとしても、上記の分解生成物に含まれるヌクレオチド類の二重らせん率が20%を超えることはない。
なお、ヌクレオプロテインを加水分解処理してオリゴペプチドを得るにはプロテアーゼ処理及びオリゴヌクレオチドを得るにはヌクレアーゼ処理が為されることとなるが、好ましくは、始めにプロテアーゼで処理し、続いてヌクレアーゼ処理することが、作業上の都合及び得られる最終生成物の品質の観点より望ましい。
As described above, DNA, RNA, and nucleoprotein are treated by hydrolysis using nuclease at 60 to 75 ° C., so that a fraction having a molecular weight of 1000 to 3000 is contained in an amount of 20 to 50%, and the molecular weight is 1000 or less. The molecular weight of the fraction is usually higher than that of the fraction having a molecular weight of 1000 to 3000, for example, 30 to 50%, thereby improving water solubility and transdermal absorbability. Combined DNA, RNA and nucleoprotein degradation products can be produced.
Nucleoprotein degradation products and DNA degradation products obtained by the above treatment contain deoxyoligonucleotides, deoxymononucleotides and oligopeptides that have been reduced in molecular weight as the main part or most of the reduced molecular weight. Insufficient deoxynucleotides and the like are contained as a very small portion.
In addition, RNA degradation products obtained by the same treatment contain oligonucleotides and mononucleotides as major parts or most parts, and nucleotides with insufficient molecular weight are contained in very small parts. .
Therefore, the nucleotides (deoxyoligonucleotides, deoxymononucleotides, oligonucleotides, mononucleotides) contained in these degradation products are almost all or most of them are mono- or complete ones that do not inherently have a helical chain. It is composed of a chain oligo body and an oligo body having only a part of a double helix structure. In other words, even if it is assumed that the above-described reduction in molecular weight has not progressed sufficiently, the double helix ratio of nucleotides contained in the degradation product does not exceed 20%.
In order to obtain an oligopeptide by hydrolyzing a nucleoprotein, a protease treatment and a nuclease treatment are required to obtain an oligonucleotide. Preferably, treatment with a protease is performed first, followed by nuclease treatment. It is desirable from the viewpoint of work convenience and the quality of the final product obtained.

本発明の化粧品用配合剤はその有効成分として、ヌクレオプロテイン及び/又はDNAを酵素分解処理又は加水分解処理して得られた分解生成物、或いは、RNAを酵素分解処理又は加水分解処理して得られた分解生成物を、そのまま(精製することなく)使用することができる。前記分解生成物中に、例えば、アミノ酸などが含まれていてもよい。
また、本発明の化粧品用配合剤の有効成分として、ヌクレオプロテイン及び/又はDNA又はRNA分解生成物から慣用の分離手段及び/又は精製手段を用いて分離・精製された以下の化合物:デオキシオリゴヌクレオチド、デオキシモノヌクレオチド、オリゴペプチド、オリゴヌクレオチド及びモノヌクレオチドを使用することができる。
このとき、ヌクレオプロテイン、DNA及びRNAの分解生成物に含まれるか、又は、該分解生成物から慣用の分離手段及び/又は精製手段を用いて分離・精製されたデオキシオリゴヌクレオチド及びオリゴヌクレオチドの鎖長は2乃至12のものであることが好ましい。
The cosmetic preparation of the present invention has, as its active ingredient, a degradation product obtained by enzymatic degradation or hydrolysis of nucleoprotein and / or DNA, or an enzymatic degradation or hydrolysis treatment of RNA. The resulting degradation product can be used as such (without purification). In the decomposition product, for example, an amino acid or the like may be contained.
In addition, as an active ingredient of the cosmetic compounding agent of the present invention, the following compound separated and purified from nucleoprotein and / or DNA or RNA degradation products using conventional separation means and / or purification means: Deoxyoligonucleotide , Deoxymononucleotides, oligopeptides, oligonucleotides and mononucleotides can be used.
At this time, deoxyoligonucleotides and oligonucleotide strands contained in the degradation products of nucleoprotein, DNA and RNA, or separated / purified from the degradation products using conventional separation means and / or purification means The length is preferably 2-12.

前記分解生成物及び前記化合物は、それぞれ単独で使用してもよいし、又は、これらの少なくとも2種類を混合して使用してもよい。
前記分解生成物や前記化合物を混合して使用する場合は、その混合比率は適宜選択し得る。
このとき、前記分解生成物及び前記化合物として、鎖長が2乃至12の前記デオキシオリゴヌクレオチド又は前記オリゴヌクレオチドのうち少なくとも何れか一方を含み、並びに鎖長が2乃至12の前記デオキシオリゴヌクレオチド及び前記オリゴヌクレオチドの含有量の合計が、前記分解生成物および前記化合物の全合計量に対して20%以上であることが特に好ましい。
The decomposition product and the compound may be used alone or in combination of at least two of them.
When the decomposition product or the compound is used in combination, the mixing ratio can be appropriately selected.
At this time, the degradation product and the compound include at least one of the deoxyoligonucleotide having a chain length of 2 to 12 or the oligonucleotide, and the deoxyoligonucleotide having a chain length of 2 to 12 and the compound. It is particularly preferable that the total content of oligonucleotides is 20% or more based on the total amount of the degradation products and the compounds.

本発明の化粧品用配合剤における有効成分(前記分解生成物及び/又は前記化合物)の濃度は適宜選択し得る。
また、前記分解生成物や前記化合物を、更に化粧品用配合剤の慣用の添加成分と所定比率で組み合わせて使用してもよい。
The concentration of the active ingredient (the decomposition product and / or the compound) in the cosmetic preparation of the present invention can be appropriately selected.
Moreover, you may use the said decomposition product and the said compound further combining with the conventional additive component of the cosmetic compounding agent in a predetermined ratio.

また、本発明の化粧品は、前記化粧品用配合剤を含有してなる。
本発明の化粧品が採り得る剤型は、皮膚に適用可能な剤型であれば適宜選択可能である。好ましくは、化粧品はローション、乳液、クリーム、ジェル、ゼリー、エッセンス、パック、マスク、ファンデーションなど、直接肌に塗布する形態であることが望ましい。またこれら化粧品は顔の皮膚だけでなく首や手足など体全体に使用することもできる。
The cosmetic of the present invention contains the cosmetic compounding agent.
The dosage form that can be taken by the cosmetic of the present invention can be appropriately selected as long as it is a dosage form applicable to the skin. Preferably, the cosmetic is in a form that is directly applied to the skin, such as lotion, emulsion, cream, gel, jelly, essence, pack, mask, foundation. These cosmetics can be used not only on the skin of the face but also on the entire body such as the neck and limbs.

本発明の化粧品には、前記化粧品用配合剤に加えて既存の化粧品に配合され得る公知の成分を配合することができる。例えば香料や保湿剤等を、単独又は組み合わせて配合することができる。   The cosmetics of the present invention can be blended with known ingredients that can be blended into existing cosmetics in addition to the cosmetic compounding agents. For example, a fragrance | flavor, a moisturizer, etc. can be mix | blended individually or in combination.

また、本発明の化粧品には、薬剤成分として、ビタミンE又はその誘導体、例えばビタミンEアセテート;アセチルコリン誘導体等の血管拡張剤;セファランチン等の皮膚機能亢進剤;グリチルレチン酸又はその誘導体;エストラジオール、エストロン等の女性ホルモン剤;セリン、メチオニン、アルギニン等のアミノ酸類;ビタミンA、ビタミンB1
ビタミンB6、ビオチン、パントテン酸又はその誘導体等のビタミン類を単独又は組み合
わせて配合することができる。
In the cosmetic of the present invention, vitamin E or a derivative thereof, for example, vitamin E acetate; a vasodilator such as an acetylcholine derivative; a skin function enhancer such as cephalanthin; glycyrrhetinic acid or a derivative thereof; estradiol, estrone, etc. Female hormone agents; amino acids such as serine, methionine, arginine; vitamin A, vitamin B 1 ,
Vitamins such as vitamin B 6 , biotin, pantothenic acid or derivatives thereof can be used alone or in combination.

更に、本発明の化粧品には、必要に応じて、通常、化粧品や医薬品等の皮膚外用剤に用いられる添加剤、例えば、油分、防腐剤、界面活性剤、分散安定剤、増粘剤、湿潤剤、紫外線吸収剤、酸化防止剤、pH調整剤、精製水及びアルコール等を単独又は組み合わせて配合することができる。   Furthermore, in the cosmetics of the present invention, additives that are usually used for external preparations for skin such as cosmetics and pharmaceuticals, for example, oils, preservatives, surfactants, dispersion stabilizers, thickeners, wetting are optionally used. An agent, an ultraviolet absorber, an antioxidant, a pH adjuster, purified water, alcohol and the like can be used alone or in combination.

以下に示す実施例及び比較例において、本発明を具体的且つ更に詳細に説明する。下記実施例は本発明の説明のためのみのものであり、これらの実施例により本発明の技術的範囲が限定されるものではない。
以下の実施例及び比較例における各成分の配合量は、全体量に対する質量%である。又、実施例で用いた試作品1乃至試作品3(DNA塩、DNA及びヌクレオプロテイン、又はRNAを、酵素分解処理して得られた分解生成物をそれぞれ含有するもの)の量は固形分量として示す。
In the following examples and comparative examples, the present invention will be described in detail and in detail. The following examples are for illustrative purposes only and are not intended to limit the technical scope of the present invention.
The compounding amount of each component in the following examples and comparative examples is mass% with respect to the total amount. In addition, the amount of prototype 1 to prototype 3 (each containing a degradation product obtained by enzymatic degradation of DNA salt, DNA and nucleoprotein, or RNA) used in the examples is the solid content Show.

1.(デオキシ)オリゴヌクレオチドの製造
鮭白子由来のDNAに対して、食品添加物として認可されているヌクレアーゼ[例えば、酵素製剤ヌクレアーゼ「アマノ」(天野エンザイム社製)]を用いて限定分解を行った。産生したデオキシモノヌクレオチドとデオキシオリゴヌクレオチドを電気泳動装置で分析して最適条件を決定した。
具体的には、65℃前後に調整した温水に原料として粉末状DNA−Na塩を投入し、撹拌後、更に70℃に加温し、原料に対してヌクレアーゼを0.05乃至0.25%の範囲で適量を加えて3時間反応させた。次に、85℃で10分間加熱してヌクレアーゼを失活させた後、遠心分離し、上澄み液にスプレードライ法を適用して、デオキシオリゴヌクレオチドを含む乾燥粉末(分解生成物)を得た。
1. Production of (Deoxy) Oligonucleotide Limited digestion was performed on DNA derived from coconut bud using a nuclease [for example, enzyme preparation nuclease “Amano” (manufactured by Amano Enzyme)] approved as a food additive. The produced deoxymononucleotide and deoxyoligonucleotide were analyzed with an electrophoresis apparatus to determine the optimum conditions.
Specifically, powdered DNA-Na salt is added as raw material to warm water adjusted to around 65 ° C., stirred, and further heated to 70 ° C., and nuclease is 0.05 to 0.25% based on the raw material. An appropriate amount was added within the range of 3 to react for 3 hours. Next, after heating at 85 ° C. for 10 minutes to inactivate the nuclease, the mixture was centrifuged, and spray drying was applied to the supernatant to obtain a dry powder (degradation product) containing deoxyoligonucleotide.

2.(デオキシ)オリゴヌクレオチドの分析
65℃前後に調整した温水に原料として鮭白子由来の粉末状DNA−Na塩を投入し、
撹拌後、更に70℃に加温し、原料に対して酵素製剤ヌクレアーゼ「アマノ」(天野エンザイム社製)を0.05%加えて3時間反応させて分解生成物を得た。次に、85℃で10分間加熱してヌクレアーゼを失活させた後、分解生成物をHPLCで分析した。
図1に、HPLC(高速液体クロマトグラフィー)による、分解生成物のデオキシオリゴヌクレオチドの分析例を示す。図1において、5'−デオキシモノヌクレオチド及び3'−デオキシモノヌクレオチドはピーク20までに溶出しており、以降の比較的大きなピーク、すなわちピーク26以後をデオキシオリゴヌクレオチドの吸収とみなすことができる。また、ピーク41以後は分子量が3000を超える分解生成物の吸収とみなすことができる。このため、ピーク26乃至41のピーク強度から算出した結果、本例では分解生成物全体に対して、31%のデオキシオリゴヌクレオチド(分子量1000〜3000)の分画が含まれていることがわかった。
2. Analysis of (deoxy) oligonucleotide A powdery DNA-Na salt derived from white coconut was added as raw material to warm water adjusted to around 65 ° C.,
After stirring, the mixture was further heated to 70 ° C., 0.05% of the enzyme preparation nuclease “Amano” (manufactured by Amano Enzyme) was added to the raw material and reacted for 3 hours to obtain a decomposition product. Next, the nuclease was inactivated by heating at 85 ° C. for 10 minutes, and then the decomposition product was analyzed by HPLC.
FIG. 1 shows an analysis example of deoxyoligonucleotides as degradation products by HPLC (high performance liquid chromatography). In FIG. 1, 5′-deoxymononucleotide and 3′-deoxymononucleotide are eluted up to peak 20, and the subsequent relatively large peak, that is, peak 26 and later, can be regarded as absorption of deoxyoligonucleotide. Further, after the peak 41, it can be regarded as absorption of a decomposition product having a molecular weight exceeding 3000. For this reason, as a result of calculating from the peak intensities of the peaks 26 to 41, it was found that in this example, a fraction of 31% deoxyoligonucleotide (molecular weight 1000 to 3000) was contained with respect to the entire decomposition product. .

3.(デオキシ)オリゴヌクレオチドを用いた化粧品の製造
前記製造方法にて得たデオキシオリゴヌクレオチドを含む乾燥粉末(DNA塩分解生成物)を試作品1とし、この試作品1を用いて、本発明の化粧品を以下のように製造した。また対照として、試作品1を含有しない化粧品を製造した。これらの組成を下記表1にまとめて示す。
[実施例1]
95%エタノールに精製水を加え、これにポリオキシエチレン(25モル)硬化ヒマシ油エーテル、グリセリン、プロピレングリコールを加えて攪拌後、試作品1を加えて攪拌溶解し、透明液状の実施例1の化粧品を得た。
[比較例1]
試作品1の代わりに同量のグリセリンを用い、実施例1と同様の製法で比較例1の化粧品を得た。
3. Manufacture of cosmetics using (deoxy) oligonucleotide A dry powder (DNA salt degradation product) containing deoxyoligonucleotide obtained by the above-described manufacturing method is used as prototype 1, and using this prototype 1, the cosmetic of the present invention Was manufactured as follows. As a control, a cosmetic product containing no prototype 1 was produced. These compositions are summarized in Table 1 below.
[Example 1]
Purified water is added to 95% ethanol, and polyoxyethylene (25 mol) hydrogenated castor oil ether, glycerin and propylene glycol are added and stirred. I got cosmetics.
[Comparative Example 1]
A cosmetic product of Comparative Example 1 was obtained in the same manner as in Example 1 except that the same amount of glycerin was used instead of Prototype Product 1.

4.皮膚画像解析システムを用いた肌状態の評価
30代及び50代の被験者を対象に、実施例1の化粧品と比較例1の化粧品を顔の左右半面ずつ、入浴後に約1g/1回/1日、それぞれ塗布した。
(株)インフォワード製ロボスキンアナライザーCS50システムセットを用いて、試験実施前(初期値)と4週間後の塗布した箇所の皮膚の状態を評価した。
4−1.水分量及び皮脂量の評価
水分量及び皮脂量の状態を、油分水分センサーを用いて測定した。センサーを左右の頬に当て、以下の測定方法及び評価基準より測定結果を評価した。
・油分(肌表面に分泌された皮脂量)
センサー部分を押し当てることで圧延された油分を屈折率により計測し、面積で評価する。全面を油分が覆った状態を「油分が飽和した状態(100)」とし、全く油分が存在
していない状態を「油分がゼロの状態(0)」として評価した。
・水分(生体表層の水分量)
センサー部分を押し当てることで肌の静電容量を計測し、水分を表す値として計測する。生理食塩水そのものを計測した状態を「飽和した状態(100)」とし、全く水分が存在しない状態を「ゼロの状態(0)」として評価した。
4−2.皮溝密度(肌のきめ)の評価
左右の頬の皮溝密度の状態を、マイクロスコープを用いて撮影し、撮影された画像をロボスキンアナライザーにて解析し、評価した。
解析方法は、撮影画像(モノクロ画像に変換)中における暗部を皮溝、明部を皮丘とし、明暗部を各々処理して二値化した結果と、一辺0.4mmの正三角形のきめモデル(顎の下の皮膚の状態を参考にしたもの)とを比較し、モデルを100として撮影画像を評価する。
4−3.しわの評価
眼下のしわの状態を全顔撮影ボックスにて測定した肌画像の解析により評価した。
撮影画像(モノクロ画像に変換)において、濃度が著しく急勾配で暗くなっている部分を眼下のしわとして検出し、しわの本数をカウントした。
4). Evaluation of skin condition using skin image analysis system For subjects in their 30s and 50s, the cosmetic product of Example 1 and the cosmetic product of Comparative Example 1 were placed on the left and right halves of the face, about 1 g / time / day after bathing. , Respectively.
Using an In-Forward Robo Skin Analyzer CS50 system set, the skin condition of the applied part before the test (initial value) and after 4 weeks was evaluated.
4-1. Evaluation of water content and sebum content The states of water content and sebum content were measured using an oil moisture sensor. The sensor was applied to the left and right cheeks, and the measurement results were evaluated by the following measurement method and evaluation criteria.
・ Oil content (the amount of sebum secreted on the skin surface)
The oil component rolled by pressing the sensor part is measured by the refractive index and evaluated by the area. The state where the entire surface was covered with oil was evaluated as “oil saturated” (100), and the state where no oil was present was evaluated as “oil free (0)”.
・ Moisture (water content of living body surface)
The capacitance of the skin is measured by pressing the sensor part and measured as a value representing moisture. The state where the physiological saline itself was measured was evaluated as “saturated state (100)”, and the state where no water was present was evaluated as “zero state (0)”.
4-2. Evaluation of skin groove density (skin texture) The state of skin groove density on the left and right cheeks was photographed using a microscope, and the photographed images were analyzed and evaluated with a Robo Skin Analyzer.
In the analysis method, the dark part in the photographed image (converted into a monochrome image) is a skin groove, the bright part is a skin hill, the light and dark part is processed and binarized, and a regular triangle texture model with a side of 0.4 mm. Compared with (referring to the condition of the skin under the chin), the model image is taken as 100 and the photographed image is evaluated.
4-3. Evaluation of wrinkles The condition of the wrinkles under the eyes was evaluated by analyzing the skin image measured in the full face photography box.
In the photographed image (converted to a monochrome image), a portion where the density was extremely steep and dark was detected as a wrinkle under the eyes, and the number of wrinkles was counted.

上記試験の評価を下記表2(被験者:30代)及び表3(被験者:50代)に、各被験者の肌状態の変化(撮影画像)を図2及び図3に示す。
また、上記試験結果と各年代の平均値を記した図(グラフ)を図4及び図5に示す。
The evaluation of the test is shown in the following Table 2 (subject: 30s) and Table 3 (subject: 50s), and the skin condition change (photographed image) of each subject is shown in FIG. 2 and FIG.
Moreover, the figure (graph) which described the said test result and the average value of each age is shown in FIG.4 and FIG.5.

表2、表3、図4及び図5に示すように、実施例1の結果は、30代、50代いずれの被験者においても水分量、皮脂量、皮溝密度の改善が見られ、特に、試験開始前に平均値を下回っていた水分量(30代、50代)及び皮溝密度(30代)は4週間経過後に平均値まで回復した。またしわの本数も4週間経過後に平均値又は平均値近くまで減少した。
また図2及び図3で示す撮影画像からも、皮溝密度(きめ)が改良されたことが目視にて確認できた。
一方、比較例1においては、配合したグリセリン等の保湿効果により、試験開始前(初期値)と比べると多少改善するか若しくは同程度の結果となったが、上記実施例1と比べるとその改善効果には大きく差を生ずる結果となった。
As shown in Table 2, Table 3, FIG. 4 and FIG. 5, the results of Example 1 showed improvement in water content, sebum content, and crevice density in subjects in their 30s and 50s. The amount of water (30's and 50's) and skin groove density (30's) that were below the average before the start of the test recovered to the average after 4 weeks. The number of wrinkles also decreased to the average value or close to the average value after 4 weeks.
Moreover, it has confirmed visually also from the picked-up image shown in FIG.2 and FIG.3 that the skin groove density (texture) was improved.
On the other hand, in Comparative Example 1, due to the moisturizing effect of the blended glycerin and the like, the result was somewhat improved or comparable to that before the start of the test (initial value), but improved compared to Example 1 above. As a result, there was a big difference in the effect.

5.DNA及びヌクレオプロテイン分解生成物(試作品2)又はRNA分解生成物(試作品3)の製造及び分析
有効成分として、日生バイオ(株)製造のDNA及びヌクレオプロテインを酵素分解処理して得られた分解生成物を含有するものを試作品2(デオキシオリゴヌクレオチド、デオキシモノヌクレオチド及びオリゴペプチドを含有するもの)とし、また、有効成分として、日生バイオ(株)製造のRNAを酵素分解処理して得られた分解生成物を含有するものを試作品3(オリゴヌクレオチド及びモノヌクレオチドを含有するもの)とした。
試作品2及び試作品3の製造方法及び分析結果は以下のとおりである。
5. Production and analysis of DNA and nucleoprotein degradation product (prototype 2) or RNA degradation product (prototype 3) Obtained by enzymatic degradation of DNA and nucleoprotein produced by Nissei Bio Inc. as active ingredients Prototype 2 (containing deoxyoligonucleotides, deoxymononucleotides and oligopeptides) containing degradation products, and obtained by enzymatic digestion of RNA produced by Nissei Bio Inc. as an active ingredient The product containing the resulting degradation product was designated as prototype 3 (containing oligonucleotide and mononucleotide).
The manufacturing method and analysis results of Prototype 2 and Prototype 3 are as follows.

5−1.試作品2(DNA及びヌクレオプロテイン分解生成物)の製造方法及び分析
試作品2は、試作品1の場合と同様の製造方法により、DNAを酵素分解処理により低
分子化して得られた分解生成物と、ヌクレオプロテインを酵素分解処理により低分子化して得られた分解生成物を等量混合したものである。各分解生成物の製造方法の詳細は以下の通りである。
<DNA分解生成物>
[製造方法]
前出の「1.(デオキシ)オリゴヌクレオチドの製造」と同様の方法により製造を行い、DNA分解生成物を得た。
[構造及び組成]
前出の「2.(デオキシ)オリゴヌクレオチドの分析」と同様の方法により分析を行い、分解生成物全体に対して、31%のデオキシオリゴヌクレオチド(分子量1000〜3000)の分画が含まれていることがわかった。
<ヌクレオプロテイン分解生成物>
[製造方法]
水に原料として鮭白子由来のヌクレオプロテイン(日生バイオ(株)製)を投入し、50℃で加熱、撹拌後、原料に対して酵素製剤プロテアーゼ「PTN」(ノボザイムズジャパン(株)製)を0.065%加えて4時間反応させ、更に70℃で加熱、撹拌する。続いて、酵素製剤ヌクレアーゼ「アマノ」(天野エンザイム社製)を0.1%加えて3時間反応させた。次に、85℃で10分間加熱してヌクレアーゼを失活させた後、遠心分離し、スプレードライ法を適用して、デオキシオリゴヌクレオチドを含む乾燥粉末(分解生成物)を得た。
[構造及び組成]
得られた上述の分解生成物をHPLCで分析した。
図6にHPLC(高速液体クロマトグラフィー)による、分解生成物のデオキシオリゴヌクレオチドの分析例を示す。図6において、保持時間19分から24分以内のピーク(ピーク1〜ピーク4)をオリゴヌクレオチドの吸収とみなすことができる。このため、ピーク1乃至4のピーク強度から算出した結果、本例では分解生成物全体に対して、33.4%のデオキシオリゴヌクレオチド(分子量1000〜3000)の分画が含まれていることがわかった。
5-1. Production method and analysis of Prototype 2 (DNA and nucleoprotein degradation products) Prototype 2 is a degradation product obtained by reducing the molecular weight of DNA by enzymatic degradation using the same production method as in Prototype 1. And an equal amount of degradation products obtained by reducing the molecular weight of nucleoprotein by enzymatic degradation. The detail of the manufacturing method of each decomposition product is as follows.
<DNA degradation product>
[Production method]
Production was carried out in the same manner as in “1. Production of (deoxy) oligonucleotide” above to obtain a DNA degradation product.
[Structure and composition]
Analysis is performed in the same manner as in “2. Analysis of (deoxy) oligonucleotide” above, and a fraction of 31% deoxyoligonucleotide (molecular weight 1000 to 3000) is contained in the entire degradation product. I found out.
<Nucleoprotein degradation products>
[Production method]
Nucleoprotein derived from white cocoon (Nissei Bio Co., Ltd.) is added to water as a raw material, heated and stirred at 50 ° C., and then the enzyme protease “PTN” (manufactured by Novozymes Japan Co., Ltd.) 0.065% is added and reacted for 4 hours, and further heated and stirred at 70 ° C. Subsequently, 0.1% of the enzyme preparation nuclease “Amano” (manufactured by Amano Enzyme) was added and reacted for 3 hours. Next, the nuclease was inactivated by heating at 85 ° C. for 10 minutes, followed by centrifugation and applying a spray drying method to obtain a dry powder (decomposition product) containing deoxyoligonucleotide.
[Structure and composition]
The obtained decomposition product was analyzed by HPLC.
FIG. 6 shows an analysis example of deoxyoligonucleotide as a decomposition product by HPLC (high performance liquid chromatography). In FIG. 6, peaks (peak 1 to peak 4) within a retention time of 19 minutes to 24 minutes can be regarded as oligonucleotide absorption. For this reason, as a result of calculating from the peak intensities of peaks 1 to 4, in this example, a fraction of 33.4% deoxyoligonucleotide (molecular weight 1000 to 3000) is included in the entire decomposition product. all right.

5−2.試作品3(RNA分解生成物)の製造方法及び分析
試作品3は試作品1の場合と同様の製造方法により、原料DNAの代わりにRNAを酵素分解処理により、低分子化して得られた分解生成物であり、詳細は以下の通りである。<RNA分解生成物>
[製造方法]
70℃前後に調整した温水に原料として酵母由来のRNA(日生バイオ(株)製)を投入し、撹拌後、更に70℃に加温し、原料に対して酵素製剤ヌクレアーゼ「アマノ」(天野エンザイム社製)を0.05%加えて3時間反応させた。次に、85℃で10分間加熱してヌクレアーゼを失活させた後、遠心分離し、スプレードライ法を適用して、オリゴヌクレオチドを含む乾燥粉末(分解生成物)を得た。
[構造及び組成]
得られた上述の分解生成物をHPLCで分析した。
図7にHPLC(高速液体クロマトグラフィー)による、分解生成物のオリゴヌクレオチドの分析例を示す。図7において、保持時間13分から24分以内のピーク(ピーク2〜ピーク5)をオリゴヌクレオチドの吸収とみなすことができる。このため、ピーク2乃至5のピーク強度から算出した結果、本例では分解生成物全体に対して、41.1%のオリゴヌクレオチド(分子量1000〜3000)の分画が含まれていることがわかった。
5-2. Production method and analysis of Prototype 3 (RNA degradation product) Prototype 3 is a degradation method obtained by reducing the molecular weight of RNA instead of raw DNA by enzymatic degradation using the same production method as in Prototype 1. Details of the product are as follows. <RNA degradation product>
[Production method]
Yeast-derived RNA (Nissei Bio Co., Ltd.) is added as raw material to warm water adjusted to around 70 ° C, stirred, and further heated to 70 ° C. The enzyme preparation nuclease "Amano" (Amano Enzyme) is added to the raw material. 0.05%) was added and reacted for 3 hours. Next, the nuclease was inactivated by heating at 85 ° C. for 10 minutes, followed by centrifugation and applying a spray drying method to obtain a dry powder (decomposition product) containing the oligonucleotide.
[Structure and composition]
The obtained decomposition product was analyzed by HPLC.
FIG. 7 shows an analysis example of oligonucleotides of degradation products by HPLC (high performance liquid chromatography). In FIG. 7, a peak (peak 2 to peak 5) within a retention time of 13 minutes to 24 minutes can be regarded as oligonucleotide absorption. For this reason, as a result of calculating from the peak intensities of peaks 2 to 5, it was found that in this example, a fraction of 41.1% of oligonucleotide (molecular weight 1000 to 3000) was contained with respect to the entire degradation product. It was.

6.各種化粧品の製造
有効成分として、日生バイオ(株)製造のDNA及びヌクレオプロテインを酵素分解処理して得られた分解生成物を含有するものを試作品2(デオキシオリゴヌクレオチド、デ
オキシモノヌクレオチド及びオリゴペプチドを含有するもの)とし、また、有効成分として、日生バイオ(株)製造のRNAを酵素分解処理して得られた分解生成物を含有するものを試作品3(オリゴヌクレオチド及びモノヌクレオチドを含有するもの)とした。
得られた試作品2及び試作品3を用いて、本発明の化粧品を以下のように製造した。また、対照として、試作品2及び試作品3を含有しない比較例の化粧品を製造した。これらの化粧品の組成を下記表4乃至表7にまとめて示す。
なお、以下の化粧品に使用した製品の入手元を括弧内に示す。
6). Manufacture of various cosmetics Prototype 2 (deoxyoligonucleotide, deoxymononucleotide and oligopeptide) containing degradation products obtained by enzymatic degradation of DNA and nucleoprotein produced by Nissei Bio Inc. as active ingredients And an active ingredient containing a degradation product obtained by enzymatic degradation of RNA produced by Nissei Bio Inc. Stuff).
Using the obtained prototype 2 and prototype 3, the cosmetic of the present invention was produced as follows. Moreover, the cosmetics of the comparative example which does not contain the prototype 2 and the prototype 3 were manufactured as a control. The compositions of these cosmetics are summarized in Tables 4 to 7 below.
In addition, the acquisition source of the product used for the following cosmetics is shown in parentheses.

6−1.ジェル状化粧品
[実施例2(実施例2−1〜2−3)]
精製水に攪拌しながらPemulen TR−1(日光ケミカルズ(株))を徐々に加え十分に分散させ、ついでUltrez−10(日光ケミカルズ(株))を攪拌分散させたところへ、濃グリセリンを加えジェル基材とした。別にレシノールWS−50(日光ケミカルズ(株))、ホホバ油、スクワラン、リアルカーブSR−1000(LIALCARB:日光ケミカルズ(株))、AMITER MA−HD(日本エマルジョン(株))及びローズヒップ油を加熱溶解混合し、油性成分とした。さらに別にセラリピッドW−2(日光ケミカルズ(株))、1,3−ブチレングリコール(BG)、ジプロピレングリコール(DPG)及び2−フェノキシエタノールを加えて過熱攪拌混合(300rpm、80℃、5分間保持)し、精製水を加えて十分攪拌した後、前記油性成分を合わせ、十分に混和し配合成分原液とした。
前記ジェル基材及び配合成分原液を混和し、これにエタノールを加えた後、18%水酸化ナトリウムを加え中和攪拌混合した。これに、精製水と混合した試作品2、試作品3及び試作品2と試作品3の等量混合物(試作品4)の各々を溶解させ、実施例2−1乃至2−3のジェル状化粧品を調製した。
[比較例2]
試作品2及び試作品3の代わりに濃グリセリンを2質量%追加し、計7質量%を添加した以外は、実施2−1、実施例2−2及び実施例2−3と同様の方法で比較例2のジェル状化粧品を調製した。
6-1. Gel-like cosmetic [Example 2 (Examples 2-1 to 2-3)]
While stirring in purified water, Pemulen TR-1 (Nikko Chemicals Co., Ltd.) was gradually added and sufficiently dispersed, and then Ultraz-10 (Nikko Chemicals Co., Ltd.) was stirred and dispersed, and then concentrated glycerin was added to the gel. A substrate was used. Separately, Resinol WS-50 (Nikko Chemicals Co., Ltd.), Jojoba Oil, Squalane, Real Curve SR-1000 (LIALCARB: Nikko Chemicals Co., Ltd.), AMITER MA-HD (Nihon Emulsion Co., Ltd.) and Rosehip Oil are heated. Dissolved and mixed to obtain an oily component. Separately, Ceralipid W-2 (Nikko Chemicals Co., Ltd.), 1,3-butylene glycol (BG), dipropylene glycol (DPG) and 2-phenoxyethanol were added and superheated with stirring (300 rpm, maintained at 80 ° C. for 5 minutes). Then, after adding purified water and stirring sufficiently, the oil components were combined and mixed thoroughly to obtain a blended component stock solution.
The gel base material and the blended component stock solution were mixed, ethanol was added thereto, 18% sodium hydroxide was added, and the mixture was neutralized and stirred. Each of the prototype 2, mixed with purified water, and a mixture of equal amounts of the prototype 2 and the prototype 3 (prototype 4) was dissolved in the gels of Examples 2-1 to 2-3. A cosmetic product was prepared.
[Comparative Example 2]
In the same manner as in Example 2-1, Example 2-2, and Example 2-3 except that 2% by mass of concentrated glycerin was added instead of prototype 2 and prototype 3, and 7% by mass in total was added. A gel cosmetic product of Comparative Example 2 was prepared.

6−2.乳液状化粧品
[実施例3(実施例3−1〜3−3)]
精製水に濃グリセリンを加え70℃に加熱調製した(水相)。別に、セチルアルコール、ミツロウ、ワセリン、スクワラン及びジメチルポリシロキサンに、モノオレイン酸エステル及びグリセロールモノステアリン酸エステルを加え70℃に加熱した。これを先に調製した水相に加え予備乳化を行った。更に、クインスシード抽出液及びエタノールを加え攪拌し、ホモミキサーで乳化粒子を均一にした。
この乳液状液体が40℃になったところで、精製水と混合した試作品2、試作品3及び試作品2と試作品3の等量混合物(試作品4)の各々を溶解させ、実施例3−1乃至3−3の乳液状化粧品を調製した。
[比較例3]
試作品2及び試作品3の代わりに濃グリセリンを2質量%追加し、計10質量%を添加した以外は、実施3−1乃至実施例3−3と同様の方法で比較例3の乳液状化粧品を調製した。
6-2. Emulsion cosmetics [Example 3 (Examples 3-1 to 3-3)]
Concentrated glycerin was added to purified water and heated to 70 ° C. (aqueous phase). Separately, monooleate and glycerol monostearate were added to cetyl alcohol, beeswax, petrolatum, squalane and dimethylpolysiloxane and heated to 70 ° C. This was added to the previously prepared aqueous phase and pre-emulsified. Furthermore, the quince seed extract and ethanol were added and stirred, and the emulsified particles were made uniform with a homomixer.
When this emulsion liquid reached 40 ° C., each of Prototype 2, Prototype 3, and an equal mixture of Prototype 2 and Prototype 3 (Prototype 4) mixed with purified water was dissolved. -1 to 3-3 milky cosmetics were prepared.
[Comparative Example 3]
The emulsion of Comparative Example 3 was prepared in the same manner as in Examples 3-1 to 3-3, except that 2% by mass of concentrated glycerin was added instead of Prototype 2 and Prototype 3, and a total of 10% by mass was added. A cosmetic product was prepared.

6−3.ローション状化粧品
[実施例4(実施例4−1〜4−3)]
精製水に1,3−ブチレングリコール、濃グリセリン、緩衝剤、褐色防止剤を室温で溶解させた。またエタノールにオレイルアルコール、ソルビタンモノラウリン酸エステル及び精製水と混合した試作品2、試作品3及び試作品2と試作品3の等量混合物(試作品4)の各々を溶解させ、これらを各々混合攪拌し、実施例4−1乃至4−3のローション状
化粧品を調製した。
[比較例4]
試作品2及び試作品3の代わりに濃グリセリンを2質量%追加し、計6質量%を添加した以外は、実施4−1乃至実施例4−3と同様の方法で比較例4のローション状化粧品を調製した。
6-3. Lotion cosmetics [Example 4 (Examples 4-1 to 4-3)]
1,3-butylene glycol, concentrated glycerin, a buffering agent and a browning inhibitor were dissolved in purified water at room temperature. Also, each of Prototype 2, Prototype 3, and Equal Mix of Prototype 2 and Prototype 3 (Prototype 4) mixed with oleyl alcohol, sorbitan monolaurate and purified water in ethanol is dissolved and mixed. The mixture was stirred to prepare lotion-like cosmetics of Examples 4-1 to 4-3.
[Comparative Example 4]
The lotion form of Comparative Example 4 was prepared in the same manner as in Examples 4-1 to 4-3 except that 2% by mass of concentrated glycerin was added instead of Prototype 2 and Prototype 3 and a total of 6% by mass was added. A cosmetic product was prepared.

6−4.クリーム状化粧品
[実施例5(実施例5−1〜5−3)]
精製水に1,3−ブチレングリコール、ペンチレングリコール、濃グリセリン、ポリクオタニウムを順次溶解し、80℃まで加熱して水相とした。他方、ステアリン酸ポリグリセリル、ステアリルアルコール、ベヘニルアルコール、バチルアルコール、パルミチン酸セチル、ステアリン酸グリセリン、クロダラン SWL(クローダジャパン(株))、パルミチン酸イソプロピル、スクワラン、ミリスチン酸オクチルドデシル、マカダミアナッツ油、トリオクタノイン、ジメチコンを混合し、85℃にて加熱攪拌して油相とした。水相に油相を注入して攪拌し(300rpm)、高粘度用ホモミキサー(4000rpm)にて乳化した。
この乳化状物質が40℃になったところで、精製水に水酸化ナトリウム、クエン酸ナトリウム及び精製水と混合した試作品2、試作品3及び試作品2と試作品3の等量混合物(試作品4)の各々を溶解させ、実施例5−1乃至5−3のクリーム状化粧品を調製した。[比較例5]
試作品2及び試作品3の代わりに濃グリセリンを2質量%追加し、計7質量%を添加した以外は、実施5−1乃至実施例5−3と同様の方法で比較例5のクリーム状化粧品を調製した。
6-4. Creamy cosmetic [Example 5 (Examples 5-1 to 5-3)]
1,3-Butylene glycol, pentylene glycol, concentrated glycerin, and polyquaternium were sequentially dissolved in purified water and heated to 80 ° C. to obtain an aqueous phase. On the other hand, polyglyceryl stearate, stearyl alcohol, behenyl alcohol, batyl alcohol, cetyl palmitate, glyceryl stearate, Crodaran SWL (Croda Japan Co., Ltd.), isopropyl palmitate, squalane, octyldodecyl myristate, macadamia nut oil, trioctanoin Dimethicone was mixed and heated and stirred at 85 ° C. to obtain an oil phase. The oil phase was poured into the aqueous phase, stirred (300 rpm), and emulsified with a high viscosity homomixer (4000 rpm).
When this emulsified substance reaches 40 ° C., trial water 2, sodium citrate and purified water mixed with purified water, prototype 3, and a mixture of prototype 2 and prototype 3 in equal amounts (prototype) Each of 4) was dissolved to prepare creamy cosmetics of Examples 5-1 to 5-3. [Comparative Example 5]
Instead of Prototype 2 and Prototype 3, 2% by mass of concentrated glycerin was added, and a total of 7% by mass was added, and the cream of Comparative Example 5 was used in the same manner as Example 5-1 to Example 5-3. A cosmetic product was prepared.

7.化粧品(ジェル、乳液、ローション、クリーム)の性能試験
実施例2乃至5及び比較例2乃至5の化粧品について、それぞれ以下の評価を行った。結果を表4乃至表7にまとめて示す。
7−1.皮溝密度(きめ)の状態
中高年女性の被験者を対象に、実施例2乃至5の化粧品並びに比較例2乃至5の化粧品を顔の左右半面ずつ、入浴後に約1g/1回/1日、それぞれ塗布した。
前記(株)インフォワード製ロボスキンアナライザーCS50システムセットを用いて、4週間後の塗布した箇所の皮膚の皮溝密度を前述の通り評価した。試験結果の判定は、下記判定基準により行った。
++:比較例に比べて塗布した部分の皮溝密度の数値が10%以上増加した(著効)
+ :比較例に比べて塗布した部分の皮溝密度の数値が5〜10%増加した(有効)
± :比較例に比べて塗布した部分の皮溝密度の数値が0〜5%増加した(やや有効)
− :比較例に比べて塗布した部分の皮溝密度の数値が同等以下であった(無効)
7). Performance test of cosmetics (gel, milky lotion, lotion, cream) The cosmetics of Examples 2 to 5 and Comparative Examples 2 to 5 were evaluated as follows. The results are summarized in Tables 4 to 7.
7-1. State of skin groove density (texture) For the subjects of middle-aged and elderly women, the cosmetics of Examples 2 to 5 and the cosmetics of Comparative Examples 2 to 5 on the left and right half of the face, about 1 g / time / day after bathing, respectively. Applied.
Using the above-mentioned Inforward Robo Skin Analyzer CS50 system set, the skin crevice density of the applied part after 4 weeks was evaluated as described above. The test results were determined according to the following criteria.
++: The numerical value of the skin groove density of the applied part increased by 10% or more compared with the comparative example (high effect)
+: The numerical value of the skin groove density of the coated part was increased by 5 to 10% compared to the comparative example (effective)
±: The numerical value of the skin groove density of the applied part increased by 0 to 5% compared to the comparative example (somewhat effective)
-: The numerical value of the skin groove density of the coated part was equal to or less than that of the comparative example (invalid)

7−2.肌荒れの改善試験
下肢に肌荒れを有する中高年女性10名を被試験対象として、実施例2乃至5の化粧品及び比較例2乃至5の化粧品をそれぞれ、左右の下肢の異なる場所に、入浴後に約1g/1回/1日、塗布した。
試験実施前と1ヵ月後の塗布した箇所の皮膚の状態により、以下の判定基準を用いて、皮膚の剥離状態と水分状態の観点から試験結果の判定を行った。
7−2−1.皮膚剥離の判定基準及び有効性の判断
試験実施前後の皮膚の剥離の状態を以下の判定基準で判断した。
0:剥離なし 1:剥離軽度 2:剥離中程度 3:剥離重度
上記判定により、試験実施後の判定が実施前より1段階改善されたものを「やや有効」とし、2段階以上改善されたものを「有効」とし、同レベル又は悪化したものは「無効」とした。
7−2−2.水分状態の判定基準
1ヶ月後の皮膚の水分状態(保湿性)を保湿計によって測定し、下記基準により判定を行った。
<水分状態の判定基準>
++:塗布した部分の保湿性が試験実施前より5%以上増加した(著効)
+ :塗布した部分の保湿性が試験実施前より2〜5%増加した(有効)
± :塗布した部分の保湿性が試験実施前より0〜2%増加した(やや有効)
− :塗布した部分の保湿性が試験実施前と同等以下であった(無効)
7-2. Skin roughness improvement test 10 middle-aged and elderly women with skin roughness in the lower limbs were tested, and the cosmetics of Examples 2 to 5 and Comparative Examples 2 to 5 were each placed at different locations on the left and right lower limbs at about 1 g / It was applied once / day.
The test results were judged from the viewpoints of the peeled state and moisture state of the skin, using the following judgment criteria, depending on the state of the skin at the place where the test was applied and one month later.
7-2-1. Criteria for skin peeling and judgment of effectiveness The state of skin peeling before and after the test was judged according to the following criteria.
0: No peeling 1: Mild peeling 2: Moderate peeling 3: Peeling severity Based on the above judgment, the result after the test was improved by one level from the level before the test was regarded as “slightly effective” and improved by two or more levels. Was “valid”, and those with the same level or worsened were “invalid”.
7-2-2. Criteria for determination of moisture state The moisture state (moisturizing property) of the skin after one month was measured with a moisturizer, and determined according to the following criteria.
<Judgment criteria for moisture status>
++: The moisturizing property of the applied part increased by 5% or more from before the test (high effect)
+: The moisturizing property of the applied part increased by 2 to 5% (effective) from before the test.
±: Moisturizing property of the applied part increased by 0 to 2% from before the test (slightly effective)
−: The moisture retention of the applied part was equal to or less than that before the test (invalid)

7−3.試用による評価試験
中高年女性を対象に、一重盲検にて、実施例2乃至5の化粧品並びに比較例2乃至5の化粧品の評価試験を行った。なお各化粧品の被試験者は10名ずつとした。評価は被試験者に対するアンケートで、「滑らかさ」、「肌理の細かさ」の2項目を、使用前と1ヶ月使用後に回答を得た。
得られた回答より、試験結果の判定は、下記判定基準により行った。
++:使用前に比べて改善した(有効)
+ :使用前に比べてやや改善した(やや有効)
± :使用前に比べて同等以下だった(無効)
7-3. Evaluation test by trial The evaluation test of the cosmetics of Examples 2 to 5 and the cosmetics of Comparative Examples 2 to 5 was conducted in a single-blind manner for middle-aged women. The number of examinees for each cosmetic product was 10. The evaluation was based on a questionnaire for the examinees, and answers were obtained before use and after 1 month of use for two items of “smoothness” and “fineness of texture”.
Based on the obtained answers, the test results were determined according to the following criteria.
++: Improved compared to before use (effective)
+: Slightly improved compared to before use (somewhat effective)
±: Less than or equal to before use (invalid)

表4乃至表7に示すように、試作品2、試作品3又は試作品4(試作品2と試作品3の等量混合物)を含有する実施例2乃至5の化粧品は、試作品2乃至4を含有しない比較例
2乃至5の化粧品と比べて皮溝密度の状態を顕著に改善した。
また、実施例2乃至5の化粧品は肌荒れ改善試験においても有効性がほぼ顕著であるとする結果が得られ、試用による評価試験においても改善効果が顕著に認められたとする試験結果が得られた。
一方、比較例2乃至5の化粧品は、肌荒れ改善試験、試用による評価試験のいずれにおいて改善効果が殆ど認められず、試作品2乃至4を含んだ化粧品の有効性が明らかとなった。
As shown in Tables 4 to 7, the cosmetics of Examples 2 to 5 containing prototype 2, prototype 3, or prototype 4 (an equivalent mixture of prototype 2 and prototype 3) are prototypes 2 to Compared with the cosmetics of Comparative Examples 2 to 5 not containing 4, the state of the skin groove density was remarkably improved.
In addition, the cosmetics of Examples 2 to 5 obtained results that the effectiveness was almost remarkable in the rough skin improvement test, and the test results that the improvement effect was remarkably recognized also in the evaluation test by trial use were obtained. .
On the other hand, the cosmetics of Comparative Examples 2 to 5 showed almost no improvement effect in both the rough skin improvement test and the evaluation test by trial use, and the effectiveness of the cosmetics including the prototypes 2 to 4 became clear.

なお、以上の実施例1乃至5では、有効成分として試作品1(DNA塩分解生成物)、試作品2(DNA及びヌクレオプロテイン分解生成物)、試作品3(RNA分解生成物)及び試作品4(試作品2と試作品3の混合物)を使用したが、試作品1乃至試作品4の代わりに、それらから分離・精製したデオキシオリゴヌクレオチド、デオキシモノヌクレオチド、オリゴペプチド、オリゴヌクレオチド又はモノヌクレオチドを単独で又は組み合わせて使用しても、試作品1乃至試作品4を使用した場合と同様に効果が認められた。   In Examples 1 to 5 described above, prototype 1 (DNA salt degradation product), prototype 2 (DNA and nucleoprotein degradation product), prototype 3 (RNA degradation product), and prototype as active ingredients. 4 (mixture of Prototype 2 and Prototype 3) was used, but instead of Prototypes 1 to 4, deoxyoligonucleotides, deoxymononucleotides, oligopeptides, oligonucleotides or mononucleotides separated and purified from them Even when these were used alone or in combination, the same effects as in the case of using prototypes 1 to 4 were recognized.

すなわち本実施例から、デオキシオリゴヌクレオチド等(デオキシオリゴヌクレオチド、デオキシモノヌクレオチド、オリゴペプチド、オリゴヌクレオチド、モノヌクレオチドのうち少なくとも一種)を含有する製剤には、肌状態(水分量、皮脂量、皮溝密度、しわ)の改善効果を有することが認められた。特に皮溝密度が改良したとする試験結果は、デオキシオリゴヌクレオチド等が細胞再生又は細胞活性化能を有することを裏付ける結果であるといえる。   That is, from this example, a preparation containing deoxyoligonucleotide or the like (at least one of deoxyoligonucleotide, deoxymononucleotide, oligopeptide, oligonucleotide, mononucleotide) has a skin condition (water content, sebum amount, skin groove). It was found to have an effect of improving density and wrinkles). In particular, it can be said that the test result that the crevice density is improved is a result supporting that deoxyoligonucleotide or the like has cell regeneration or cell activation ability.

以下に、上記試作品1乃至試作品4を用いた化粧品の処方例を、実施例6乃至8として示す。なお、ここで記載した「試作品(類)」とは、試作品1乃至3を其々単独で、或いは試作品2と試作品3の当量混合物(試作品4)から選択されるいずれかの意味を表すものとする。
いずれの実施例においても肌の水分量及び皮脂量の改善並びに皮溝密度の状態を改良し、しわの減少効果を有することが認められ、試用によってその効果を認めることができた。
肌の滑らかさ及び肌理の細かさを改善する効果を有することが認められた。
Examples of prescription of cosmetics using the prototypes 1 to 4 are shown as Examples 6 to 8 below. The “prototype (class)” described here is any one selected from prototypes 1 to 3 alone or an equivalent mixture of prototype 2 and prototype 3 (prototype 4). It shall represent meaning.
In any of the examples, it was confirmed that the skin water content and sebum content were improved, and the condition of the crevice density was improved, and the effect of reducing wrinkles was observed.
It was found to have an effect of improving the smoothness and fineness of the skin.

実施例6:コールドクリーム
<製造方法>
精製水に試作品(類)、石鹸粉末を加え加熱溶解して70℃に保った(水相)。他の成分を混合し、加熱融解して70℃に保った(油相)。水相に油相を撹拌しながら徐々に加え、終了後、ホモミキサーで均一に乳化し、乳化後よく撹拌しながら30℃まで冷却し、コールドクリームを調製した。
Example 6: Cold cream
<Manufacturing method>
Prototype (s) and soap powder were added to purified water and dissolved by heating and kept at 70 ° C. (aqueous phase). The other components were mixed, heated and melted and kept at 70 ° C. (oil phase). The oil phase was gradually added to the aqueous phase with stirring, and after completion, the mixture was uniformly emulsified with a homomixer. After emulsification, the mixture was cooled to 30 ° C. with good stirring to prepare a cold cream.

実施例7:クレイパック
<製造方法>
1,3−ブチレングリコール、グリセリン、セスキステアリン酸PEG−20セチルグルコース、キサンタンガム、防腐剤、精製水を混合・撹拌して全体を均一とした。
これをホモミキサーで撹拌しながら、試作品(類)及びカオリンを加え、全体を均一とし、さらにエタノールを加えて撹拌・混合し、クレイパックを調製した。
Example 7: Clay pack
<Manufacturing method>
1,3-butylene glycol, glycerin, PEG-20 cetyl glucose sesquistearate, xanthan gum, preservative, and purified water were mixed and stirred to make the whole uniform.
While stirring this with a homomixer, the prototype (s) and kaolin were added to make the whole uniform, and ethanol was further added and stirred and mixed to prepare a clay pack.

実施例8:ファンデーション
<製造方法>
オレイン酸グリセリン、ジイソステアリン酸トリグリセリル、シクロヘキサンジオクチル、セチルアルコール、マイクロクリスタリンワックス、流動パラフィン、トリメチルシロキシケイ酸液、タルク及び酸化鉄を加熱溶解し、混合した(A)。グリセリン、硫酸マグネシウム及び精製水を混合して加熱し、(A)を加えて混合した後冷却した。ここに試作品(類)を精製水に溶解して加え、次に殺菌剤及び香料を加えて、ベースファンデーションを調製した。
Example 8: Foundation
<Manufacturing method>
Glycerin oleate, triglyceryl diisostearate, cyclohexanedioctyl, cetyl alcohol, microcrystalline wax, liquid paraffin, trimethylsiloxysilicate solution, talc and iron oxide were dissolved by heating and mixed (A). Glycerin, magnesium sulfate and purified water were mixed and heated, (A) was added and mixed, and then cooled. A prototype (s) was dissolved in purified water and added, and then a fungicide and a fragrance were added to prepare a base foundation.

図1は、DNAのヌクレアーゼ処理品(分解生成物)の、HPLCによるデオキシオリゴヌクレオチドの分析例を示す図である。FIG. 1 is a diagram showing an analysis example of deoxyoligonucleotide by HPLC of a nuclease-treated product (degradation product) of DNA. 図2は、30代被験者の試験実施前と試験開始4週間後の肌状態の変化を示す撮影画像である。FIG. 2 is a photographed image showing changes in the skin condition of subjects in their 30s before the test and four weeks after the start of the test. 図3は、50代被験者の試験実施前と試験開始4週間後の肌状態の変化を示す撮影画像である。FIG. 3 is a photographed image showing changes in the skin condition of subjects in their 50s before the test and four weeks after the start of the test. 図4は、水分量及び皮脂量の試験結果と各年代の平均値を示す図である。FIG. 4 is a diagram showing the test results of the moisture amount and sebum amount and the average values for each age. 図5は、皮溝密度及びしわの試験結果と各年代の平均値を示す図である。FIG. 5 is a diagram showing the results of skin groove density and wrinkle tests and the average values for each age. 図6は、ヌクレオプロテインのヌクレアーゼ処理品(分解生成物)の、HPLCによるデオキシオリゴヌクレオチドの分析例を示す図である。FIG. 6 is a diagram showing an analysis example of deoxyoligonucleotide by HPLC of a nucleoprotein nuclease-treated product (degradation product). 図7は、RNAのヌクレアーゼ処理品(分解生成物)の、HPLCによるオリゴヌクレオチドの分析例を示す図である。FIG. 7 is a diagram showing an analysis example of oligonucleotides by HPLC of RNA nuclease-treated products (degradation products).

Claims (6)

RNAを酵素分解処理又は加水分解処理により低分子化して得られた分子量1000乃至3000の画分であって、鎖長が2乃至12のオリゴヌクレオチドを20乃至50%含有するRNA分解生成物を含有する皮溝密度を改良する化粧品用配合剤(但しβ−アラニンを含有する配合剤を除く)。 A fraction with a molecular weight of 1000 to 3000 obtained by reducing the molecular weight of RNA by enzymatic degradation or hydrolysis, and containing an RNA degradation product containing 20 to 50% of an oligonucleotide having a chain length of 2 to 12 A cosmetic preparation for improving the crevice density (except for a preparation containing β-alanine). 前記RNA分解生成物は、鎖長が2乃至12のオリゴヌクレオチドを41.1%含有するものであることを特徴とする、請求項1に記載の皮溝密度を改良する化粧品用配合剤。 The cosmetic preparation for improving the crevice density according to claim 1, wherein the RNA degradation product contains 41.1% of an oligonucleotide having a chain length of 2 to 12. 前記RNA分解生成物はビール酵母、トルラ酵母、乳酵母及びパン酵母からなる群より選択される酵母から得ることを特徴とする、請求項1又は請求項2に記載の化粧品用配合剤。 The cosmetic preparation according to claim 1 or 2, wherein the RNA degradation product is obtained from a yeast selected from the group consisting of beer yeast, torula yeast, milk yeast and baker's yeast. 前記RNA分解生成物に加えて、さらにヌクレオプロテイン及びDNAを酵素分解処理又は加水分解処理により低分子化して得られた分子量1000乃至3000の画分であって、鎖長が2乃至12のデオキシオリゴヌクレオチドを20乃至50%含有するヌクレオプロテイン分解生成物及びDNA分解生成物を含有する、請求項1記載の化粧品用配合剤。 In addition to the RNA degradation product, a deoxyoligomer having a molecular weight of 1000 to 3000 obtained by lowering the molecular weight of nucleoprotein and DNA by enzymatic degradation or hydrolysis, and having a chain length of 2 to 12 The cosmetic preparation according to claim 1, comprising a nucleoprotein degradation product containing 20 to 50% nucleotides and a DNA degradation product. 前記ヌクレオプロテイン及びDNAは鮭、鱒、鰊及び鱈からなる群から選択される魚類の白子から得ることを特徴とする、請求項4に記載の化粧品用配合剤。 5. The cosmetic preparation according to claim 4, wherein the nucleoprotein and DNA are obtained from a fish larva selected from the group consisting of salmon, salmon, salmon and salmon. 請求項1乃至請求項5のいずれか1項に記載の化粧品用配合剤を含有することを特徴とする皮溝密度を改良する化粧品。
A cosmetic for improving the skin groove density, comprising the cosmetic compounding agent according to any one of claims 1 to 5.
JP2006344971A 2006-08-09 2006-12-21 Cosmetic preparations and cosmetics for improving the skin groove density Active JP5025254B2 (en)

Priority Applications (5)

Application Number Priority Date Filing Date Title
JP2006344971A JP5025254B2 (en) 2006-08-09 2006-12-21 Cosmetic preparations and cosmetics for improving the skin groove density
KR1020070052609A KR20080013702A (en) 2006-08-09 2007-05-30 Compounding ingredients for cosmetic formulation for improving skinditch density and cosmetic formulation
US11/902,764 US20080153741A1 (en) 2006-12-21 2007-09-25 Compounding ingredients for cosmetic formulation for improving skinditch density and cosmetic
EP07019175A EP1938794A2 (en) 2006-12-21 2007-09-28 Compounding ingredients for cosmetic formulation for improving skinditch density and cosmetics
CNA2007101691948A CN101259084A (en) 2006-12-21 2007-09-29 Compounding ingredients for cosmetic formulation for improving skinditch density and cosmetic

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP2006217368 2006-08-09
JP2006217368 2006-08-09
JP2006344971A JP5025254B2 (en) 2006-08-09 2006-12-21 Cosmetic preparations and cosmetics for improving the skin groove density

Publications (2)

Publication Number Publication Date
JP2008063315A JP2008063315A (en) 2008-03-21
JP5025254B2 true JP5025254B2 (en) 2012-09-12

Family

ID=39286317

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2006344971A Active JP5025254B2 (en) 2006-08-09 2006-12-21 Cosmetic preparations and cosmetics for improving the skin groove density

Country Status (2)

Country Link
JP (1) JP5025254B2 (en)
KR (1) KR20080013702A (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP6153736B2 (en) * 2013-02-08 2017-06-28 フォーデイズ株式会社 Cancer cell growth inhibitor and health food
KR101520386B1 (en) * 2014-12-26 2015-05-15 아람휴비스(주) An apparatus for maunfacturing customized cosmetics
JP6555674B1 (en) * 2018-07-24 2019-08-07 ジェネティックバイオラボ株式会社 Anti-aging agent for skin and anti-aging-related gene expression regulating agent
KR101955261B1 (en) * 2018-07-30 2019-03-08 이봉수 Cosmetic composition and method thereof
KR102311011B1 (en) * 2018-09-12 2021-10-08 주식회사 엘지생활건강 A composition for promoting the proliferation of human adipose derived stem cell
JP7015064B2 (en) * 2019-08-05 2022-02-02 日生バイオ株式会社 Keratin plug remover
CN116120385B (en) * 2023-04-04 2023-06-23 尚诚怡美(成都)生物科技有限公司 Trigonella Foenum nucleic acid with triple helix structure and preparation method and application thereof

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2381451A (en) * 2001-11-01 2003-05-07 New Technology Res Ltd Pharmaco-dietary preparation having nutrition-supplementing and nutrition-enhancing effect
JP3978716B2 (en) * 2002-04-18 2007-09-19 日生バイオ株式会社 Gene oxidative damage inhibitor
JP2004016142A (en) * 2002-06-18 2004-01-22 Ls Corporation:Kk Formulation containing collagen and water soluble decomposed product of nucleoprotein
JP2004016143A (en) * 2002-06-18 2004-01-22 Ls Corporation:Kk Method for producing water soluble decomposed product of nucleoprotein
FR2864539B1 (en) * 2003-12-30 2012-10-26 Lvmh Rech OLIGONUCLEOTIDE AND USE THEREOF FOR MODULATING THE EXPRESSION OF BETA-1 PROTEIN-KINASE C ISOFORM AS CUTANEOUS DEPIGMENTING AGENT
JP4599518B2 (en) * 2005-06-13 2010-12-15 日生バイオ株式会社 Hair care preparations
JP5025253B2 (en) * 2006-03-31 2012-09-12 日生バイオ株式会社 Formulation for basic cosmetics and basic cosmetics

Also Published As

Publication number Publication date
KR20080013702A (en) 2008-02-13
JP2008063315A (en) 2008-03-21

Similar Documents

Publication Publication Date Title
EP0790054B1 (en) Composition and method for under-eye skin lightening and against eye puffiness
KR101353628B1 (en) Compounding ingredients for basic cosmetics and basic cosmetics
JP5025254B2 (en) Cosmetic preparations and cosmetics for improving the skin groove density
JP2009234980A (en) Cosmetic composition incorporating cell growth factor blended with neuraminic acids and placenta
EP1938867A2 (en) Compounding ingredients for basic cosmetics and basic cosmetics
IL157814A (en) Cosmetic composition comprising camel milk or components thereof
KR20080015066A (en) Hair care preparation
JP2010173991A (en) External preparation for skin
JP2004323401A (en) Skin care preparation for external use
US20080153741A1 (en) Compounding ingredients for cosmetic formulation for improving skinditch density and cosmetic
KR20180118409A (en) Nutrition Cream Containing Ergothioneine and Its Manufacturing Method
RU2591789C1 (en) Cosmetic composition for face and neck skin care
JP2006219432A (en) Composition having rough skin-preventing activity, cosmetic and beverage
JP2011246372A (en) Beauty set for improving symptom of aging of skin of neck, and beauty method using the same
CN105796461A (en) Moisturizing and repairing lotion containing hydrolyzed pearl essence flexible nano-liposomes and sea buckthron oil
JP2004224742A (en) Skin care preparation
JP2007023024A (en) Preparation for hair care
JP3044690B2 (en) Cosmetics
JP2002272417A (en) Method for extraction of rice bran, the resultant extract thereby and cosmetic, skincare article, detergent and food additive each containing the extract
JP2009249366A (en) Collagen production promotor and anti-aging skin preparation for external use
JP2006219431A (en) Composition having rough skin-preventing activity, cosmetic and beverage
CN109620795A (en) A kind of whitening and spot eliminating cream and preparation method thereof of releiving of the ferment powder containing whitening
JP2004035431A (en) Skin care preparation for externa use
CN107519119A (en) A kind of snake gall anti-acne essence cream and preparation method thereof
JP5527917B2 (en) Arginase activity promoter and skin external preparation containing the same

Legal Events

Date Code Title Description
A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20090306

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20110308

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20110330

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20110527

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20120307

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20120316

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20120509

A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20120619

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20150629

Year of fee payment: 3

R150 Certificate of patent or registration of utility model

Ref document number: 5025254

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150

Free format text: JAPANESE INTERMEDIATE CODE: R150

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20150629

Year of fee payment: 3

FPAY Renewal fee payment (event date is renewal date of database)

Free format text: PAYMENT UNTIL: 20150629

Year of fee payment: 3

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313114

R371 Transfer withdrawn

Free format text: JAPANESE INTERMEDIATE CODE: R371

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313114

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313117

R371 Transfer withdrawn

Free format text: JAPANESE INTERMEDIATE CODE: R371

S111 Request for change of ownership or part of ownership

Free format text: JAPANESE INTERMEDIATE CODE: R313117

S531 Written request for registration of change of domicile

Free format text: JAPANESE INTERMEDIATE CODE: R313531

R350 Written notification of registration of transfer

Free format text: JAPANESE INTERMEDIATE CODE: R350